Postoperative BMI Changes and Functional Outcomes in Knee and Hip Arthroplasty
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Jun 1, 2024
Trial Information
Current as of February 08, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who underwent primary TKA and THA with a 2-year follow-up were included
- Exclusion Criteria:
- • Patients who underwent bariatric surgery before or after the surgery
- • Incomplete 2-year follow-up
- • Whom BMI or Oxford scores could not be accessed
Trial Officials
Cumhur Deniz Davulcu
Principal Investigator
Istanbul University - Cerrahpasa
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Fatih, Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0